The Development of MetAP-2 Inhibitors in Cancer Treatment
Keywords: Angiogenesis inhibitor; MetAP-2; MetAP-2 inhibitors; antiangiogenesis; cancer; endothelial cells; fumagillin; metastasis; methionine; migration; structure-activity relationship; vascular endothelial growth factor
Document Type: Research Article
Publication date: 2012-03-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.